Structure

Developer of oral small molecule drugs for chronic diseases

placeSan Francisco, California, United States calendar_todayFounded 2017 groups93 employees language structuretx.com

Registered entities

Social engagement

Social engagement: 14K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include BVF Partners; 1 has since exited.

Investor typeCountShare
Venture capital947%
Private equity316%
Bank & private debt211%
Other / undisclosed526%
Coming soon